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Voltage sensor domains (VSDs) are a feature of voltage gated ion channels (VGICs) and
voltage sensitive proteins. They are composed of four transmembrane (TM) segments
(S1–S4). Currents leaking through VSDs are called omega or gating pore currents. Gating
pores are caused by mutations of the highly conserved positively charged amino acids
in the S4 segment that disrupt interactions between the S4 segment and the gating
charge transfer center (GCTC). The GCTC separates the intracellular and extracellular water
crevices. The disruption of S4–GCTC interactions allows these crevices to communicate
and create a fast activating and non-inactivating alternative cation-selective permeation
pathway of low conductance, or a gating pore. Gating pore currents have recently
been shown to cause periodic paralysis phenotypes. There is also increasing evidence
that gating pores are linked to several other familial diseases. For example, gating
pores in Nav1.5 and Kv7.2 channels may underlie mixed arrhythmias associated with
dilated cardiomyopathy (DCM) phenotypes and peripheral nerve hyperexcitability (PNH),
respectively. There is little evidence for the existence of gating pore blockers. Moreover, it
is known that a number of toxins bind to the VSD of a specific domain of Na+ channels.
These toxins may thus modulate gating pore currents. This focus on the VSD motif opens
up a new area of research centered on developing molecules to treat a number of cell
excitability disorders such as epilepsy, cardiac arrhythmias, and pain. The purpose of the
present review is to summarize existing knowledge of the pathophysiology, biophysics,
and pharmacology of gating pore currents and to serve as a guide for future studies aimed
at improving our understanding of gating pores and their pathophysiological roles.
Keywords: ion channels, voltage sensor domain, channelopathies, gating charge transfer center, sodium channels,
omega pores
INTRODUCTION
In the late 1940s, Hodgkin and Huxley were the first to high-
light the importance of ionic movements in cell excitability.
They showed that the process was mediated by dedicated struc-
tures now known as ion channels (Hodgkin and Huxley, 1952).
Thirty-two years later, the first voltage sensitive ion channel was
cloned (Noda et al., 1984). To date, at least 140 similar structures
have been identified and assigned to the voltage gated ion chan-
nel (VGIC) superfamily (Yu and Catterall, 2004). Most of these
VGICs (113 of 140) feature a voltage sensor domain (VSD) and
thus belong to the VSD-featuring protein superfamily (Figure 1).
Two structures are very common in this superfamily: the pore
domain (PD) and the VSD. Based on ion selectivity, functional
similarities, and structural homology, this superfamily can be
divided into five main types: proteins lacking a PD, voltage gated
sodium and calcium channels (Nav, Cav), voltage gated potas-
sium channels (Kv), cyclic nucleotide gated channels (CNG), and
transient receptors potential channels (TRPs).
The PD motif is present in channels that require the assem-
bly of four VSD and PD motifs to form functional units. The
PD is composed of two transmembrane (TM) segments and
a re-entrant pore loop that links the segments (Figure 1). The
assembly of four independent motifs forms tetrameric units that
are frequently found in Kv, CNG, and bacterial Nav channels.
The assembly of four motifs into four domains of the same pro-
tein (DI to DIV) is a characteristic of mammalian Nav and Cav
channels (Figure 1). The two-pore channels (TPC) sub-family
should be treated as an exception since it requires the assembly
of only two units to form a functional unit. Each unit features
two domains that assemble as a dimer to create a functional
channel. The assembly of four PD motifs creates a permeation
pathway that is responsible for the passage of ions from one side
of the membrane to the other. The ionic selectivity of the chan-
nels is mainly provided by four to five highly conserved amino
acids in the PD of Nav, Cav, and Kv channels [DEKA, EEDD,
and (T/S)XG(Y/F)G, respectively] (Heinemann et al., 1992; Doyle
et al., 1998; Valiyaveetil et al., 2006).
VSDs are composed of four TM segments (S1–S4) (Figure 1)
and are present in most VGICs and in a few other proteins such
as the voltage gated proton channel (Hv1) and TPTE. These
proteins do not require the assembly of four domains to cre-
ate a functional unit. To date, only the Hv1 and TPTE proteins
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FIGURE 1 | Phylogenic representation of the VSD-featuring protein
superfamily. The relationships between the amino acid sequences of
various human proteins that feature one or more VSD motifs are
represented as a circular phylogenic tree. The proteins are from the VGIC
family (Yu and Catterall, 2004). Channels that do not feature a VSD motif
were eliminated while proteins known to feature a VSD motif were
included (Iwasaki et al., 2008; Musset et al., 2011). The complete
sequences for each protein were aligned using Clustal Omega (Sievers
et al., 2011). The phylogenic tree was then created using a custom Matlab
script using the single linkage method. It highlights the five subgroups of
the human VSD-featuring protein superfamily. Nav and Cav channels are in
shades of purple. These proteins have a VSD motif in each of their four
homologous domains. TPCs are in blue. The fact that they feature a VSD
motif in their two homologous domains sets them apart from the other
members of the VSD-featuring protein superfamily. The structures of Kv
channels are in dark green. Since some of these channels share structural
similarities with calcium-activated potassium channels (KCa) channels and
CNG channels, the Kv7, Kv10, Kv11, and Kv12 channels were placed next
to the CNG and KCa families. The structures of the CNG and KCa families
are in light green, while the structures of TRP channels are in orange.
Members of the PD-lacking group of proteins are in black. The 2-D
structures show the VSDs in light gray and the PDs in dark gray.
have been assigned to the category of proteins that do not fea-
ture a PD motif. However, the C15orf27 protein, which may
contain a VSD, could likely be added to this category (Musset
et al., 2011). Even if this category of proteins does not contain
many members, studying it may lead to the discovery of similar
proteins that play important physiological roles (Capasso et al.,
2011).
The voltage sensitivity of the VSD-featuring channel and
protein superfamily is provided by the interaction of several
highly conserved charged residues. The S4 segment contains at
least three positively charged residues (arginines and lysines)
(Figure 2) while the S1, S2, and S3 segments contain organized
structures of highly conserved negatively charged amino acids
(aspartate and glutamate) as well as highly conserved aromatic
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies April 2014 | Volume 5 | Article 53 | 2
Moreau et al. Ion channel gating pores
FIGURE 2 | Sequence alignment of the four TM segments of VSDs
from the VSD-featuring protein superfamily. The Nav1.4, Nav1.5,
Cav1.1, and Kv7.1 channels are shown. Members of the VSD-featuring
protein superfamily such as Hv1 and C15orf27 are also shown. The
S1, S2, and S3 segments contain highly conserved negatively charged
and aromatic residues while the S4 segment contains at least three
positively charged residues. Highly conserved residues are in bold
colors. Positively charged residues are in blue (arginine or lysine),
negatively charged residues are in red (aspartate or glutamate), and
aromatic residues are in green (phenylalanine or tyrosine). The
residues involved in the GCTC are annotated as F1, F2, E1, D1, and
R0 to R6.
amino acids (tryptophan, phenylalanine, or tyrosine) (Figure 2).
Under the effect of voltage, the S4 segment moves toward the
extracellular medium and causes a conformational change that
results in the opening of the pore (Yang and Horn, 1995; Yang
et al., 1996). The nature of this movement has been the subject of
much debate. Three main models had been proposed: the sliding
helix model (Catterall, 1986), the helical-screw model (Guy and
Seetharamulu, 1986) and the paddle model (Jiang et al., 2003).
Recent progress in modeling techniques has shown that the dis-
placement of S4 is likely a blend of all three models (Delemotte
et al., 2011). However, in order to clarify and better under-
stand the nature of the movement of S4, studies have focused
on the highly conserved residues shown in Figure 2. In 2004,
Starace and Bezanilla substituted the first highly conserved argi-
nine by a histidine on the S4 segment of the Shaker K+ channel
(R362H) (Starace and Bezanilla, 2004). This mutation was ini-
tially used to study the extracellular accessibility of the residue
at rest. Interestingly, this study revealed that a proton (H+) leak
current was created following the arginine-to-histidine substitu-
tion (Starace and Bezanilla, 2004). The authors concluded that
the paddle model would have to be modified to reconcile the pro-
posed structure and the experimental data. In a subsequent study,
Tombola et al. showed that the neutralization of the first argi-
nine on the S4 segment induced a cation leak through the VSD
(R362A/C/H/S/V in the Shaker channel). The newly formed pore
through which this leak occurred was called an omega pore (also
known as a gating pore) to differentiate it from the physiologi-
cal permeation pathway known as the alpha pore (Tombola et al.,
2005).
THE VOLTAGE SENSOR DOMAIN AND THE STRUCTURE OF
GATING PORES
Voltage sensitivity is important for a wide variety of physiolog-
ical functions (Yu et al., 2005). Many voltage sensitive proteins
(VSPs) share a common structural motif called the VSD. VSDs
are assemblies of four TM segments (S1–S4) (Figure 1). The S4
segment seems to be the central pillar of gating pores given that it
drives conformational changes of VSDs. S4 is especially affected
by voltage changes since it features several highly conserved pos-
itively charged amino acids (arginines or lysines) (Figure 2).
Conserved residues on S1, S2, and S3 (Figure 2) appear to be
involved either in the stabilization of S4 in different conforma-
tional states (Tao et al., 2010; Pless et al., 2011) or in the shape of
the water crevices surrounding S4 (Pless et al., 2011). These water
crevices are very important for focusing the electric field around
the S4 segment. Alterations to the water crevices may change the
movement kinetics of VSDs without necessarily changing the sta-
bility of their various states (Pless et al., 2011). There is also a
complex of three highly conserved amino acids at the center of
each VSD. This complex forms the gating charge transfer cen-
ter (GCTC) (Figure 3) (Tao et al., 2010) and is composed of
one aromatic residue (phenylalanine, tryptophan, or tyrosine)
and two negatively charged residues (aspartic acid and glutamic
acid) (Figure 3). The aromatic residue can interact with arginines
through a cation-π interaction (Pless et al., 2011), but it prefer-
entially interacts with lysine to stabilize the activated or resting
state of VSDs (Tao et al., 2010; Pless et al., 2011). The GCTC sep-
arates the intracellular and extracellular water crevices (Figure 3),
which gives rise to a hydrophobic septum that also modulates
the kinetics of the S4 segment. The larger the septum, the higher
the free energy barrier is. As such, charged amino acids such as
arginine and lysine need more energy to move through the sep-
tum. A large hydrophobic septum would delay the onset of the
movement of S4 and changes its voltage sensitivity. Differences in
the sizes of the hydrophobic septa of the domains of the Nav1.4
channel have been reported (Gosselin-Badaroudine et al., 2012a).
Interestingly, the hydrophobic septum in domain IV is larger than
the septa of the other domains. This is illustrated by comparing
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FIGURE 3 | 2-D and 3-D schematic representations of the GCTC. The 2-D
structure of the Nav1.4 channel is shown in (A). The VSD motifs of the four
domains are in light gray while the PD motifs are in dark gray. Highly
conserved amino acids in the VSD motifs are in color. The blue, red, and
green dots represent positively charged, negatively charged, and aromatic
residues, respectively. The 3-D assembly of the Nav1.4 DI VSD motif in its
resting state, as published by Gosselin-Badaroudine et al. is shown in
(B) (Gosselin-Badaroudine et al., 2012a). The model features the water
crevices (light blue), the conserved arginine and lysine residues (dark blue),
the conserved aspartate and glutamate residues (red), and the conserved
tyrosine residue (green). As can be seen from the model, the first arginine
residue is close to the GCTC. A schematic representation of the VSD motif in
its resting state in the presence and absence of the first positively charged
amino acid (the first arginine residue) is shown in (C). This representation
highlights the fact that the neutralization of the amino acid in the R1 position
would allow the water crevices to communicate when the VSDs are in the
resting state and thus induce gating pore currents (Gosselin-Badaroudine
et al., 2012a).
the hydrophobic regions of domains I and IV (Figure 4). This
larger septum in domain IV would explain the delayed activa-
tion of this VSD (Chanda and Bezanilla, 2002). A large septum
would likely involve slower conformational changes to VSDs and
be linked to more stable resting states.
Neutralizing the positively charged amino acid interacting
with the GCTC at a given state creates a gating pore (Starace and
Bezanilla, 2004; Tombola et al., 2005). If the charges of the GCTC
are not counterbalanced by the charges of S4, the region becomes
hydrophilic. The change from hydrophobic to hydrophilic implies
that the water crevices are no longer separated, which allows ions
to permeate through the newly formed narrow pore (Figure 3).
Such pores have been used to probe the structures of the VSDs
of various proteins (Starace and Bezanilla, 2004; Tombola et al.,
2005; Gamal El-Din et al., 2010). They have also been used to
explain features of VSDs in physiological conditions (Klassen
et al., 2008; Berger and Isacoff, 2011; Musset et al., 2011) as well
as pathological phenotypes (Sokolov et al., 2007; Struyk et al.,
2008; Gosselin-Badaroudine et al., 2012b). However, caution is
warranted when drawing conclusions based solely on the exis-
tence and modulation of a gating pore current. Specifically, it has
been suggested that R362 (the first arginine residue on S4) inter-
acts with E283 (the first highly conserved glutamate on S2) in
the Shaker channel since an E283D mutation introduced into an
R362C background increases the gating pore current (Tombola
et al., 2005). It appears that, in the wild type (WT) channel, R362
is closer to F290 (the first highly conserved phenylalanine on S2)
(Figure 2) than E283. Residues located below this site preferen-
tially form Zn2+ bridges with residues located above R362 (Lin
et al., 2011). For instance, Lin et al. substituted a poorly conserved
residue located below E283 (the I287 residue) with a histidine.
In the background of this mutation, ∼56% of the channels that
also featured a R362H mutation could be momentarily trapped
in their resting state when Zn2+ was present in the extracellu-
lar solution, indicating that Zn2+ can interact with both newly
introduced histidine residues to form a Zn2+ bridge. However,
in the background of the I287H mutation, the A359H substitu-
tion was more efficient at trapping the channels in their resting
state since all the channels formed a Zn2+ bridge, indicating that
I287 is closer to A359 than to R362, which would thus be located
in close proximity to residues below I287. This is in agreement
with reports that the positively charged residues of the S4 seg-
ment interact with the highly conserved aromatic amino acid in
the S2 segment as observed in Kv channels (Tao et al., 2010).
However, this does not negate the fact that the R362C/E283D
double mutant yields a larger gating pore than the R362C sin-
gle mutant, which would indicate that mutant VSDs may feature
stable conformational states slightly different from their WT
counterparts. While we believe in the validity of the published
reports, we advise caution. Indeed, to develop an artifact-free
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FIGURE 4 | The hydrophobic septum of domain IV is larger. The 3-D
assembly of the Nav1.4 DI and DIV VSD motifs in their resting state, as
published by Gosselin-Badaroudine et al. (2012a). The segments S1 of both
VSDs have been removed for clarity. As illustrated, the model indicates a
considerably larger septum in domain IV, probably explaining its slower
kinetics. Depicted here are: the water crevices (light blue), the conserved
arginine and lysine residues (dark blue), the conserved aspartate and
glutamate residues (red), and the conserved tyrosine residue (green).
structural model of VSDs, interactions between highly conserved
amino acids uncovered by the detection of gating pore currents
should be confirmed using other techniques. For example, the
creation of Zn2+, Mg2+, or cysteine bridges created using less
critical, more poorly conserved residues located near the interac-
tion of interest should confirm whether or not the more poorly
conserved residues are in close proximity. It would be reason-
able to conclude that the interactions of conserved residues also
occur in WT channels if mutant channels featuring disruptive
mutations (mutations yielding gating pore currents) and less dis-
ruptive mutations (mutations yielding bridges) point to the same
conclusion.
BIOPHYSICAL PROPERTIES OF GATING PORES
GATING OF GATING PORES
Voltage-dependence
Gating is paramount when describing ionic conductances. This
property makes it possible to discriminate between ionic conduc-
tances. As mentioned previously, gating pores are open when the
interaction between the S4 segment and the GCTC is abolished
(Figures 3, 4), which means that gating pores can be created in
both the resting state (Figure 5B) (Starace and Bezanilla, 2004;
Tombola et al., 2005) and the activated state (Figure 5C) (Sokolov
et al., 2008). In addition, few investigators have reported that
mutations of the arginines interacting with the GCTC during
the transition from the resting state to the activated state result
in proton transport through VSDs, which is very similar to
gating pore currents (Figure 5D) (Starace and Bezanilla, 2001,
2004).
Since the gating of gating pores is state-dependent, the prob-
ability of a gating pore being open at a given voltage is directly
related to the probability of observing the VSD in the state
of interest. A two-state Boltzmann distribution can be used to
determine the probability of finding a VSD in a given state as a
function of the membrane potential (Armstrong and Bezanilla,
1973). This allows the charge movement to be traced as a function
of the voltage relationship (Q-V) (Figure 5A).
According to Boltzmann’s law of distribution, the probability
of observing a given particle (a VSD) in a given energy state is
proportional to the following exponential (Equation 1):
p ∝ e−E/kT (1)
where “k” is Boltzmann’s constant, “T” is the temperature, and
“E” is the energy at which the particle is observed.
Since we assume a two-state system, the probability of observ-
ing the VSD in its activated state or in its resting state is 1. Thus,
the proportion of VSDs observed in a given state is represented by
Equation (2):
P1 = 1
1 + e−(E1 − E2)/kT (2)
Since the energy is normally applied as an electrical potential, the
equation is usually written as:
Pactivated = 1
1 + e zqe(v1/2 − vm)/kT (3)
where “z” is the equivalent charge movement, “qe” is the elemen-
tary charge, “Vm” is the electrical potential at which VSDs are
observed, and “V1/2” is the electrical potential at which half the
VSDs are in their activated state.
Such a statistical distribution implies that the VSDs transition
to the activated state as a function of voltage, expressed by the
following equation:
dPactivated
dV
= zqee
(v1/2 − vm)/kT
kT(e zqe(v1/2 − vm)/kT + 1)2 (4)
This indicates that not all VSDs change states at the same voltage.
Moreover, the area under the energy distribution curve from 0
to a given voltage represents the proportion of VSDs that have a
sufficient amount of energy to be observed in their activated state
at the given voltage (Figure 5A).
The Q-V curve directly fits the Boltzmann equation of
a two-state system mentioned earlier. The opening probabil-
ity of the gating pore is given by the Q-V curve for VSDs
for which the S4-GCTC interaction is suppressed in the acti-
vated state (Equation 3). In the case of an S4-GCTC inter-
action suppressed in the resting state, the opening proba-
bility is given by 1minus the Q-V curve. This means that
the gating pore can either be defined as an inward rectify-
ing conductance if the S4-GCTC interaction is suppressed in
the resting state or as an outward rectifying conductance if
the S4-GCTC interaction is suppressed in the activated state
(Figure 5).
H+ transport due to the suppression of the S4-GCTC inter-
action in transition states is a special case as this H+ transport
is maximal when the transition rate of the VSD is maximal
(Figure 5D). The transition rates are maximal at the V1/2 of the
Q-V curve, which is also the voltage value at which the number
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FIGURE 5 | Schematic representation of the different types of gating
pores and the typical current–voltage curves of their gating pore currents.
A plot of the probability of observing a hypothetical VSD in its activated (green)
or resting state (blue) is shown in (A). In this case, the hypothetical VSD would
have a V1/2 of −50mV and a k of −12mV. The probability as a function of
voltage was calculated using Equation (2) (see text). The probability that the
VSD transits from one state to another as a function of voltage is given by
Equation (4) (see text) and is shown in orange. The schematic representations
of the WT VSD in the activated and resting states are shown in (A). The typical
current–voltage curves of gating pores opened in the resting state of the VSD
and in the activated state of the VSD are shown in (B,C), respectively. The
schematic representations of VSDs with gating pores are shown on the side.
These representations highlight the fact that gating pore currents occur when
the interaction between the positively charged S4 segment and the GCTC is
suppressed. The highly conserved aromatic and negatively charged amino
acids that make up the GCTC are shown in green and red, respectively. The
schematic representations also show that gating pore currents are blocked
when the S4-GCTC interaction is restored. A current–voltage curve of proton
transport through the VSD as reported by Starace and Bezanilla (2001) is shown
in (D). The mechanism by which this transport occurs is shown on the left.
Briefly, proton transport requires an arginine-to-histidine substitution. When
this substitution occurs on arginine residues that interact with the GCTC when
the VSD is not fully activated, no gating pore is formed in the stable states.
However, the substituted residue is accessible to water in both the resting and
activated states. This means that the histidine can be protonated in the
activated state of the VSD and deprotonated in the resting state of the VSD.
of VSDs changing states is the highest (as seen by the energy
distribution curve) (Figure 5). Such H+ transport has already
been observed with Shaker K+ channels (Starace and Bezanilla,
2004).
Kinetics
The activation kinetics of gating pores are very rapid,
with its onset being less than 1ms. Once activated, gating
pores do not inactivate since VSDs tend to stay in their
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activated state until the TM voltage returns to hyperpolarizing
values.
Due to their nature, the biophysical characteristics of gating
pores are intimately linked to the state, environment, and move-
ment of the S4 segment. This provides several advantages, notably
for structure-function studies. As such, the voltage-dependence of
gating pore currents can be used as a read-out of the movement of
individual voltage sensors (Gosselin-Badaroudine et al., 2012a).
SELECTIVITY AND CONDUCTANCE OF GATING PORES
Selectivity
Few studies have investigated the selectivity of gating pores
(Table 1) (Tombola et al., 2005; Sokolov et al., 2007; Klassen et al.,
2008; Berger and Isacoff, 2011; Francis et al., 2011). The selectivity
sequences reported by Tombola et al., Sokolov et al., and Francis
et al. indicate that gating pores may typically be more permeable
to large cations than small cations (Tombola et al., 2005; Sokolov
et al., 2007; Francis et al., 2011). The selectivity sequences thus
seem to converge toward Eisenmann’s first or second sequence,
which corresponds to the selectivity sequences of narrow pores
with weak binding sites (Eisenman, 1962). Such pores rely heavily
on ion dehydration to limit permeation to large ions (Figure 6).
Small ions, which have a high charge density, need more energy
to dehydrate. This gives them a larger effective radius, which
decreases their relative permeability (Figure 6).
NMDG+ (N-Methyl-D-Glucamine) and TEA+ (Tetra-Ethyl
Ammonium), two cations that are larger than K+, have been
reported to flow through gating pores (Sokolov et al., 2007;
Francis et al., 2011). Interestingly, the conductance values for
NMDG+ and TEA+are lower than for K+. This seems to contra-
dict the hypothesis that gating pores typically follow Eisenmann’s
first two selectivity sequences. Once dehydrated, NMDG+ and
TEA+ would either be small enough or too big to flow through
this permeation pathway. In this case, gating pores would be less
permeable to K+than to NMDG+ or TEA+since their charge
density is lower (Figure 6). However, the studies reporting that
NMDG+ and TEA+ flow through gating pores were both per-
formed with extracellular solutions adjusted to pH 7.4. It is thus
possible that the currents were the result of the permeation of H+
rather than NMDG+ or TEA+.
It has been reported that some mutations involving histidine
substitutions in the Shaker, Nav1.4, andNav1.5 channels yield gat-
ing pores that are selective to H+ alone (Starace and Bezanilla,
2004; Campos et al., 2007; Struyk and Cannon, 2007; Gosselin-
Badaroudine et al., 2012a,b). It is noteworthy that the permeation
of H+ through VSDs is postulated to occur via a Grotthus hop-
ping mechanism via water wires on each side of the membrane
(Starace and Bezanilla, 2004).
Indirect evidence for the flow of anions through mutant Hv1
channels has recently been reported (Musset et al., 2011). It would
thus be interesting to investigate this type of permeation in other
VSDs.
Conductance of gating pores
Several data sets describe the conductance of gating pores
(Table 2) (Cherny et al., 2003; Starace and Bezanilla, 2004;
FIGURE 6 | Schematic representation of Eisenmann’s principle. This
figure shows two VSDs embedded in the cytoplasmic membrane. For the
sake of simplicity, the S4 segments were removed so that the permeation
pathway of the gating pore could be seen more clearly. The permeation of
Na+ and Cs+ ions are shown on the left and right, respectively. Ions are in
gray while their hydration shells are in dark blue. The hydration shells for
small monovalent ions such as Na+ are larger than the hydration shells for
larger monovalent ions such as Rb+ and Cs+. This is due to the fact that
the charge density of Na+ ions is larger than that of Cs+ ions. While both
ions possess the same charge, Na+ ions are smaller. Na+ ions are more
tightly bonded to water molecules and require more energy to break the
bond. This energy may be provided by a binding site in the pore. In gating
pores, the GCTC, which is composed of one aromatic and two negatively
charged amino acids (in green and red, respectively) may act as binding
sites. In such narrow pores, a weak binding site would result in a lower
relative conductance of Na+ ions than of Cs+ ions. Based on currently
available selectivity sequences (Table 1), gating pores would have a weak
binding site.
Table 1 | Selectivity sequences of various gating pores.
Channel Mutation Location Selectivity References
dShaker R362C R1 Guanidium > Cs > K > Li Tombola et al., 2005
rNav1.4 R666G DII/R2 Cs ∼ K > Na ∼ Li > TEA ∼ NMDG Sokolov et al., 2007
N.at-Kv3.2 None∗ None∗ K > Cs ∼ Guanidium > Na ∼ Ba Klassen et al., 2008
hHv1 R211S R3 Guanidium > Li > H > Cs ∼ K ∼ Na Berger and Isacoff, 2011
rNav1.4 R1125Q DIII/R2 K > Na >> NMDG Francis et al., 2011
*For the gating pore of N.at-Kv3.2, no substitution was required to induce a gating pore.
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Table 2 | Conductance values reported for various gating pores.
Channel Mutation Location Conductance Ion used for
measurement
Evaluation mode References
dShaker R362H R1 40 fS H+ Fluctuation analysis Starace and Bezanilla,
2004
dShaker R362C and R362C/E283D R1 and S2/E1 100–600 fS K+ Iω/Iα Tombola et al., 2005
dShaker A359G/R362S R0 and R1 1410 fS K+ Fluctuation analysis Tombola et al., 2007
dShaker R362S/E283D/S357C/M356D R1, S2/E1 and others 3420 fS K+ Fluctuation analysis Tombola et al., 2007
rNav1.4 R666G DII/R2 530 fS Na+ Iω/Iα Sokolov et al., 2007
rNav1.4 R663H DII/R1 0,17 fS H+ Iω/Qon Struyk and Cannon, 2007
rNav1.4 R666H and R666G DII/R2 34 fS not clear (H+
and/or Na+)
Iω/Qon Struyk et al., 2008
rNav1.4 R669Q, R669G and R669W DII/R3 1060 fS Na+ Iω/Iα Sokolov et al., 2008
rNav1.4 R666G DII/R2 530 fS Na+ Iω/Iα Sokolov et al., 2010
rNav1.4 R1125Q DIII/R2 34 fS Na+ Iω/Qon Francis et al., 2011
hNav1.5 R219H DI/R1 400 fS H+ Iω/Iα Gosselin-Badaroudine
et al., 2012b
rNav1.4 R219H, R663H and R1125H DI/R1, DII/R1 and DIII/R2 210–420 fS H+ Iω/Iα Gosselin-Badaroudine
et al., 2012a
hHv1 None∗ 38–400 fS H+ Fluctuation analysis Cherny et al., 2003
Evaluation modes:
Fluctuation analysis: Analysis of the variance of the current as per Sigworth (1980).
Iω /Qon: Normalization of the gating pore current to the observed gating charge.
Iω /Iα : Normalization of the gating pore current to the maximum current of the alpha pore.
∗ For hHv1, the neutral residue in the R4 position appears to be involved in the creation of a conduction pathway through the VSD.
Sokolov et al., 2007, 2008, 2010; Struyk and Cannon, 2007;
Tombola et al., 2007; Struyk et al., 2008; Francis et al., 2011;
Gosselin-Badaroudine et al., 2012a,b). Given the diversity of the
gating pores investigated and the methods used to carry out the
investigations, no consensus seems to have emerged concerning
the conductance of gating pores. To compare the conductance
values obtained from different studies, we converted all the val-
ues into Siemens (Table 2). In these cases, some assumptions had
to be made. At voltages of -140mV and lower, the assumption
was that the open probability for gating pores at hyperpolariz-
ing voltages is 1. Given that, at this voltage, the current follows
Ohm’s law, the conductance should be maximal, and the driv-
ing force should be the only parameter impacting the value of the
current value. Nevertheless, there is evidence that the open prob-
ability for gating pores might not be 1 in such cases (Tombola
et al., 2007). Assuming unitary conductances of 25 pS and 22 pS
for the alpha pores of the Nav1.4 and Nav1.5 channels, respec-
tively (Gellens et al., 1992; Chahine et al., 1994a), we calculated
the corresponding conductance values based on the gating pore
currents measured, the voltages at which they were measured, and
the solutions used (Table 2). The values measured and calculated
span a wide range (0.17–1060 fS for gating pores created with sin-
gle mutations and up to 3400 fS for gating pores created with
multiple mutations) (Table 2). Interestingly, major discrepancies
have been reported in the values of gating pore conductances
of the Nav1.4/R666G mutant channel using similar techniques
(Sokolov et al., 2007, 2008, 2010; Struyk and Cannon, 2007;
Struyk et al., 2008). The discrepancies may be mostly due to the
different mutations and the wide variety of proteins (Table 2).
The conductance of pores created by arginine-to-histidine
mutations should be treated as special cases since their perme-
ation mechanism is different. Arginine-to-histidine mutations
yield gating pore currents that are highly selective for H+. The
conductance of these pores would be primarily modulated by the
accessibility of the histidine residue to the GCTC. When the histi-
dine residue is very close to the GCTC and the water crevices are
deep, the pores would display high conductances.
NATURALLY OCCURRING GATING PORES
GATING PORE CURRENTS IN PHYSIOLOGICAL CONDITIONS
When observed in living organisms, gating pore currents are
mainly described as a pathogenic process associated with nat-
urally occurring mutations. Nevertheless, they can be found
in few physiological conditions. The Hv1 channel (also called
HVCN1 or VSOP) is structurally composed of four TM seg-
ments with cytoplasmic C- and N-termini (Capasso et al.,
2011) (Figure 1). Interestingly, this protein does not feature
the S5–S6 motif frequently associated with selective ion con-
duction (Figure 1). However, this channel is similar to the
VSDs of other VGICs (Figures 1, 2) (Ramsey et al., 2006;
Sasaki et al., 2006). It has been reported that H+ ions
can permeate the protein via the VSD using a proton-wire
mechanism (Nagle and Morowitz, 1978; Decoursey, 2013).
According to the definition of gating pore currents put for-
ward by Tombola et al. (2005), Hv1 currents can be consid-
ered as gating pore currents. Physiologically, the activation of
this channel causes an efflux of cytoplasmic H+(Decoursey,
2003).
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Hv1 plays key roles in numerous processes such as phagocy-
tosis, spermatozoa maturation, and B cell activation (Capasso
et al., 2011). The activation of Hv1 results in the regulation of
NADPH (Nicotinamide Adenine Dinucleotide Phosphate) func-
tion, ensuring an optimal pH in phagocytosis vesicles (Decoursey,
2003). The Hv1 channel is also involved in cardiac function
(El Chemaly et al., 2006). The involvement of gating pore cur-
rents mediated by Hv1 in a wide array of functions highlights its
physiological importance.
Naturally occurring gating pore currents in platyhelminthes
(flat worms) are another example of the involvement of gating
pores in physiological functions. A K+ channel expressed in flat
worms (N.at − Kv3.2) naturally conducts ions through the VSD
(Klassen et al., 2008). These channels display unusual properties
compared to other Kv channels of the Shaw family (Kv3 fam-
ily) (Klassen et al., 2006). Surprisingly, WT N.at-Kv3.2 channels
exhibit inward-rectifier currents that are activated by hyperpo-
larization. The N.at-Kv3.2 protein structure is composed of six
TM. Its pore region is very similar to that of other Kv channels.
However, the S4 helix features two atypical residues (a histidine
and a glycine) in positions where the first and third arginines are
usually found (Figure 2) (Klassen et al., 2008). This enables the
permeation of cations through the VSDs of N.at-Kv3.2 channels
due to the lack of positively charged residues on S4 (Figure 2).
Hyperpolarization-activated currents in these channels are gat-
ing pore currents. In this flat worm, gating pore currents would
be involved in their physiological functions. Unfortunately, their
exact physiological role is unknown.
ARE GATING PORES A FEATURE OF EVOLUTION?
Klassen et al. proposed that gating pores in N.at-Kv3.2 have
evolved to produce a non-selective cation channel resulting in
the creation of a new molecular property (Klassen et al., 2008)
adapted for a specific physiological need. From an evolution-
ary point of view, VGICs could be the result of the evolution
of a unique TM segment (an S3-like segment) (Kumanovics
et al., 2002) that is responsible for sensing membrane curva-
ture. This unique TM could then have evolved into a VSD, which
would have become fine-tuned for voltage sensing before cou-
pling with pre-existing pores. This assembly would form the
VGIC (Kumanovics et al., 2002). Such an assembly is in agree-
ment with the discovery of other channels such as Hv1, which
are only composed of a VSD (Ramsey et al., 2006; Capasso
et al., 2011) and voltage-dependent phosphatases such as Ciona
intestinalis voltage-sensitive phosphatase (Ci-VSP) (Murata et al.,
2005). These phosphatases are examples of a different evolution-
ary pathway of the VSD motif. Indeed, depending on the subtype
of protein assembly, different physiological functions can appear.
In this case, Ci-VSP is directly coupled to and activated by a VSD
(Murata et al., 2005). Later in the evolutionary process, four sub-
units composed of a VSD and a pore domain fused to form Nav
and Cav channels (Kumanovics et al., 2002). Even if the natu-
rally occurring gating pores in N.at-Kv3.2 can be considered as
evolutionary precursors of VSDs, they are (together with Hv1)
the only known naturally occurring gating pores. Most known
gating pores are in vitro creations, or are of pathological origin,
which would likely exert negative selection pressure and decrease
the probability of conserving these gating pores throughout the
evolutionary process.
PATHOLOGIES LINKED TO GATING PORE CURRENTS
PERIODIC PARALYSIS
Hypokalemic periodic paralysis
Hypokalemic periodic paralysis (HypoPP) is a rare autosomal
dominant disorder characterized by recurrent attacks of paralysis
in the presence of low serum K+ (< 3mEq/L). Paralysis episodes
can be triggered by carbohydrate-rich meals, exercise, exposure
to cold, fever, or emotional stress (Cannon, 2006; Sung et al.,
2012). The current explanation for these paralysis attacks is that
the resting membrane potential (VREST) changes from −85mV
to −60mV under hypokalemic conditions, leading to muscle
fiber inexcitability (Rudel et al., 1984; Jurkat-Rott et al., 2009).
To date, 16 mutations on the CACNA1S and SCN4A genes have
been shown to cause HypoPP-1 and HypoPP-2, respectively
(Figure 7). These two genes encode Cav1.1 and Nav1.4, respec-
tively. Missense mutations have been found on their S4 segments
(six for CACNA1S and ten for SCN4A, Figures 2, 6) (Jurkat-
Rott et al., 2012; Groome et al., 2014). Mutations on CACNA1S
account for approximately 60% of HypoPP cases while mutations
on SCN4A account for 10% (Tricarico and Camerino, 2011).
Initial studies have revealed that missense mutations cause some
discrete changes in currents carried by the mutated channels
(Lapie et al., 1996; Morrill et al., 1998; Jurkat-Rott et al., 2000).
Interestingly, mutations causing HypoPP are reported to result in
a number of changes to the biophysical properties of the chan-
nels. For example, some HypoPP mutations on Cav1.1 may solely
affect current density while others may result in slower channel
activation (Lapie et al., 1996; Morrill et al., 1998). On the other
hand, HypoPP mutations on Nav1.4 are reported to lead to diver-
gent biophysical defects since they result in enhanced or reduced
channel inactivation (Jurkat-Rott et al., 2000). Nevertheless, these
changes cannot fully explain the depolarization observed during
paralysis episodes (Cannon, 2010). The specific location of the
mutations on the S4 segments (Figure 7) of the two genes led the
researchers to focus on finding a common pathologic mechanism.
Gating pore currents were described as the common mechanism
leading to the muscular pathology (Sokolov et al., 2007; Struyk
and Cannon, 2007). At this juncture, two types of mutations have
been described: mutations leading to the creation of a cationic
leak (Sokolov et al., 2007) andmutations leading to the creation of
an H+-specific leak (arginine-to-histidine substitutions) (Struyk
and Cannon, 2007).
Several processes have been proposed to explain this pathol-
ogy. Primarily, the elevation of VREST induces the inactivation
of Nav1.4 thus abrogating the ability to excite muscle fibers. The
VREST of a muscular fiber is mainly set by Kir (Inward Rectifier
Potassium Channels) (Hibino et al., 2010; Wu et al., 2011). In
severe hypokalemia (<1mM), Kir activity is reduced. In HypoPP,
the inward Na+or H+leak induced by mutations of Nav1.4 or
Cav1.1 inhibits Kir currents under relatively low kalemia condi-
tions (2.5–3mM K+) (Figure 8). The reduction in the outward
K+ current then causes an elevation in VREST (Struyk et al., 2008;
Jurkat-Rott et al., 2009; Cannon, 2010; Tricarico and Camerino,
2011; Wu et al., 2011). Gating pore currents also induce a Na+
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FIGURE 7 | Locations of mutations potentially associated with the
creation of gating pores in Nav and Cav channels. The 24 TM segments
are shown on a 2-D representative structure of a Nav or a Cav channel.
Mutations associated with DCM are indicated by blue circles, periodic
paralysis phenotypes linked to Nav1.4 mutations are indicated by green
symbols. Periodic paralysis phenotypes linked to Cav1.1 mutations are
indicated by red pentagons and stars. The epilepsia-linked mutation is
indicated by a purple diamond and familial hemiplegic migraine mutations, by
orange triangles. Malignant hyperthermia susceptibility and familial episodic
pain linked mutations are respectively indicated by red and purple circle.
overload in muscle fibers, which has already been reported by
Jurkat-Rott et al. (Jurkat-Rott et al., 2009). The Na+ overload fur-
ther destabilizes ionic homeostasis (Figure 8). Several membrane
exchangers can also be activated, including Na+/K+ ATPase,
Na+/H+, Na+/Ca2+, Na+/Lac−, and Na+/bicarbonate. Na+/H+
exchangers usually extrude H+ from the cell to regulate the inter-
nal pH. However, this exchanger may work in reverse mode
(Hilgemann et al., 2006), which would result in intracellular aci-
dosis. In addition, the exact downstream events resulting from a
Na+ overload are not fully understood. Nevertheless, detrimen-
tal consequences have been described (Pieske et al., 2003; Maack
et al., 2006; Kohlhaas et al., 2010). A Na+ overload may also
increase the mitochondrial production of reactive oxygen species
(Kohlhaas et al., 2010), which would result in an increase in oxida-
tive stress, leading to cellular remodeling as well as excitation-
contraction uncoupling, and electrical disturbances (Pieske et al.,
2003; Maack et al., 2006; Kohlhaas et al., 2010).
Mutations that induce H+-selective gating pores are linked to
the same phenotype as mutations that induce cation-selective gat-
ing pores (Struyk et al., 2008) (Figure 8), indicating that they have
similar downstream consequences although through slightly dif-
ferent mechanisms. This could be explained by the activity of the
exchangers described previously. H+ leaks and intracellular acid-
ification can have specific impacts on muscular fibers, including
the blockade of Kir(Figure 8) (Tricarico and Camerino, 2011),
which would increase the depolarization process. Acidification
can also lead to connexin uncoupling (Bukauskas et al., 2001) and
the impairment of excitation-contraction coupling by decreas-
ing the affinity of troponin C for Ca2+(Figure 8) (Fabiato and
Fabiato, 1978; Ball et al., 1994; Palmer and Kentish, 1994; Parsons
et al., 1997). HypoPP muscle fibers display certain peculiarities
such as the formation of vacuoles (vacuolar myopathy) and tubu-
lar aggregates (Sternberg et al., 2001; Jurkat-Rott et al., 2009;
Tricarico and Camerino, 2011; Wu et al., 2011). Wu et al. also
reported that sarcoplasmic triads are dilated in their HypoPP
knock-in mouse model (Wu et al., 2011, 2012). All these mor-
phological changes, while they have not been studied in depth,
attest to the diverse impacts of gating pore currents (H+-specific
or not). Unfortunately, the processes leading to morphological
changes are unknown.
Wu et al. recently described the link between HypoPP-1 and
mutations on Cav1.1. They used a knock-in mouse model and
reported that gating pore currents are induced in Cav1.1 channels
featuring an arginine-to-histidine mutation in the S4 segment
(Wu et al., 2012). Their study confirmed that the pathogenic pro-
cess leading to HypoPP-1 may be similar to the process described
for HypoPP-2.
K+-sensitive normokalemic periodic paralysis
At physiological K+ concentrations, some patients express a vari-
ant of HypoPP called K+-sensitive normokalemic periodic paral-
ysis (NormoPP). Vicart et al. identified three new mutations of
the third arginine of the S4 segment of DII of the human Nav1.4
protein (R675G/Q/W) (Figure 7) (Vicart et al., 2004). A bio-
physical study of these mutants showed that gating pore currents
appeared under depolarized conditions while the usual biophys-
ical properties were only slightly impacted (Sokolov et al., 2008).
The main characteristic of these gating pore currents is an ionic
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FIGURE 8 | Proposed pathogenic mechanism associated with the
creation of a gating pore. Schematic representation of a myocyte with its
main ionic channels and exchangers. The contractile proteins, the
sarcoplasmic reticulum, and connexins are in gray, purple, and blue,
respectively. The appearance of a gating pore current induces a
disequilibrium of ionic homeostasis through the activation of several
exchangers such as Na+/H+ and Na+/Ca2+. This would result in a Ca2+
overload. The disequilibrium then destabilizes the resting membrane
potential, connexin activity, and excitation-contraction coupling. The
pathogenic mechanism resulting in the creation of a cation-selective gating
pore current is not shown here. However, it would be similar to the
pathogenic mechanism resulting in a proton-selective gating pore current.
A cation-selective gating pore current would inhibit Kir channels, thus
increasing the resting membrane potential. A gating pore current would
inhibit the Na+/H+ exchanger and activate the Na+/Ca2+ exchanger. This
would result in acidosis and a Ca2+ overload.
leak when Nav1.4 is in the activated state (mostly K+ efflux) and
slow-inactivated state (mostly Na+ influx) (Sokolov et al., 2008).
The Na+ influx during the slow-inactivated state occurs when the
membrane potential is hyperpolarized. The mutations may stabi-
lize the S4 segment in the activated state (Sokolov et al., 2008).
Vicart et al. attributed the pathological mechanism to the large
increase in the Na+ influx in the slow-inactivated state. Recently,
the R1242Gmutation on Cav1.1 channels has also been associated
with the development of NormoPP (Fan et al., 2013). Gating pore
currents have been recorded in the depolarized state, suggesting
a common pathological mechanism. The study also confirmed
that an inward gating pore current can be recorded under hyper-
polarized voltages after a long depolarization period (Fan et al.,
2013). Interestingly, the R1135H/C mutations have recently been
associated to the development of HypoPP phenotype (Groome
et al., 2014). These mutations also induce gating pore activated
by depolarization. Furthermore, the study reveals the presence
of gating pore current under hyperpolarized conditions probably
associated with the freezing of the VSD after long depolarizations.
Intriguingly, Lee et al. described a patient affected by myotonia
that was triggered by cold exposure and that was associated with
transient weakness (Lee et al., 2009). The genetic study revealed
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the presence of a SCN4A mutation that changed the third R of
DI of the S4 segment to a W (R225W) (Figures 2, 6). While the
clinical phenotype was not classified as HypoPP or NormoPP,
the mutation was strongly associated with the development of
muscular weakness. The creation of a gating pore, which is acti-
vated by depolarization due to the mutation, is highly probable
(Figure 5C) and may be the cause of the pathology.
MIXED ARRHYTHMIAS ASSOCIATED WITH DILATED
CARDIOMYOPATHY
DCM is the most common cardiac disorder. It is characterized
by left ventricular dilatation (>117%) and systolic dysfunction
(ejection fraction inferior to 45%) (Richardson et al., 1996; Taylor
et al., 2006; McNair et al., 2011). DCM has a prevalence of 1
in 2500 and an annual incidence of 7 in 100,000 a year (Taylor
et al., 2006). Some 20–48% of DCM cases are classified as familial
DCM (Hershberger and Siegfried, 2011). To date, 33 genes, most
of which code for cytoskeleton or contractile proteins, have been
associated with familial DCM (Hershberger and Siegfried, 2011).
McNair et al. recently reported that SCN5A is linked to 1.7% of
familial DCM cases (McNair et al., 2011). The SCN5A gene codes
for the cardiac Nav1.5 channel, which is responsible for the initi-
ation of the action potential in the heart. Its role is comparable to
that of Nav1.4 in skeletal muscles. So far, 18 SCN5A mutations
have been associated with the development of severe arrhyth-
mias and heart dilatation. Ten of the mutations are located on
the VSD (S216L, R219H, T220I, R222Q, R225W, R814W, R814Q,
D1275N, V1279I, and D1595H) (Figure 7) (Bezzina et al., 2003;
McNair et al., 2004; Frigo et al., 2007; Ge et al., 2008; Hershberger
et al., 2008; Hedley et al., 2009; McNair et al., 2011; Gosselin-
Badaroudine et al., 2012b; Laurent et al., 2012). While Nav1.5
dysfunctions are commonly linked to rhythm disturbances such
as type 3 Long QT Syndrome (LQTS), Brugada Syndrome (BrS),
Sick Sinus Syndrome (SSS), or conduction defects (Amin et al.,
2010), dysfunctions of this protein have also been linked to
a morphological defect (Gosselin-Badaroudine et al., 2012b).
Interestingly, the phenotype observed in cases of DCM-linked
SCN5A mutations is a combination of complex arrhythmias
and cardiac dilatation. In addition, while mutated Nav1.5 pro-
teins cause different biophysical defects, the clinical phenotypes
reported clearly show major similarities (Table 3). We recently
linked the R219H mutation on the SCN5A to mixed arrhythmias
and the DCM phenotype, although the classic biophysical prop-
erties of the mutant protein are not affected (Table 3) (Gosselin-
Badaroudine et al., 2012b). We described a 29-year-old patient
who suffered from cardiac dilatation associated with complex
arrhythmias including bradycardia, atrial flutter, atrio-ventricular
block, and tachycardia (Table 3) (Gosselin-Badaroudine et al.,
2012b). Since the mutated residue was the first highly conserved
arginine on the S4 segment of DI (Figures 2, 6), the lack of
alterations to the biophysical properties of the channel led us
to search for a gating pore current. Our study revealed that the
R219H mutation induces a proton-specific gating pore current
(Gosselin-Badaroudine et al., 2012b). Given the location of the
other mutations associated with similar phenotypes (Figure 7),
we propose that the generation of gating pore currents may be
the common underlying mechanism that links all the phenotypes
(Table 3) (Gosselin-Badaroudine et al., 2013).While all the muta-
tions are not located on the S4 segment, mutations on the S1, S2,
or S3 segment may allow the water crevices to communicate and
induce gating pore currents (Figure 7).
In a recent review, Jurkat-Rott et al. classified the R225Q/W
and R814Q SCN5A mutations as type 3 LQTS (Jurkat-Rott et al.,
2012). They proposed that the substitution of these highly con-
served arginines on the S4 segment (Figure 2) creates a gating
pore. Interestingly, the original articles describing these muta-
tions report that LQTS is associated with other arrhythmias
and heart morphology abnormalities (Bezzina et al., 2003; Frigo
et al., 2007). Here again, the presence of gating pores due to the
mutations was not investigated.
The molecular mechanisms for the pathogenic process lead-
ing to the development of this complex pathology may be similar
to the process observed in HypoPP (Figure 8). The H+ leak (or
possibly non-specific cation leak) might imbalance the VREST of
cardiomyocytes and trigger the arrhythmias. Intracellular acidifi-
cationmay also have an impact on connexin conductance, uncou-
pling intercellular communication (Bukauskas et al., 2001). The
cardiac remodeling may be due to the major imbalance in ionic
homeostasis. Gating pore currents, combined with the activity of
numerous exchangers, may thus cause significant changes in Na+,
Ca2+, and H+ concentrations, which would decrease the affinity
of troponin for Ca2+(Figure 8). Cardiac contraction disturbances
have been reported to result from alterations to the affinity of tro-
ponin for Ca2+(Liu et al., 2012). This would lead to a reduction
in contractile strength, which in turn would result in an impaired
ejection fraction. Moreover, the uncoupling of sarcomeric pro-
teins may have an impact on the cellular structure, leading to
cardiac remodeling and DCM.
However, this cardiac remodeling may also be the result of
weakened contractions in a background of normal blood pressure
on the heart walls. Unfortunately, the morphological structure of
cardiomyocytes has not been studied in great depth, which lim-
its our understanding of the pathological processes. Lastly, gating
pore currents caused by other Nav1.5 mutations (Figure 7) need
to be recorded to confirm that gating pore currents are a common
mechanism linked to the development of familial DCM.
PERIPHERAL NERVE HYPEREXCITABILITY
Peripheral nerve hyperexcitability (PNH), also known as neu-
romyotonia, is a motor neuron dysfunction with heterogeneous
clinical symptoms. PNH has a prevalence of <1 in 1 million. Two
main subtypes of PNH can be distinguished, i.e., the autoimmune
and the non-autoimmune form. Among the non-autoimmune
forms, 2 of the 3 subtypes of hereditary PNH are channelopathies.
The most common symptoms include skeletal muscle overac-
tivity, muscle twitching and painful cramps (Jurkat-Rott et al.,
2010).
The KCNQ2 gene encodes the Kv7.2 K+ channel which con-
tributes to the neuronal non-inactivating M-current (Cannon,
2006). These Kv7.2 channels are broadly expressed in the brain
and the spinal cord (Schroeder et al., 1998; Dedek et al., 2001).
In physiological conditions, Kv7.2 channels are co-expressed with
Kv7.3 channels to form heterotetramers responsible for the M-
current. The slow opening of these channels mainly sets the
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resting membrane potential and thus modulates the neuronal
firing frequency (Hernandez et al., 2008). Most known muta-
tions of the Kv7.2 channel are associated with the development
of neonatal epilepsy known as benign familial neonatal convul-
sion (BFNC). These Kv7.2 mutations are mainly localized in the
PD, the intra and cellular loops. The contribution of this channel
to the disease manifestation could thus be due to its role in setting
the neuronal resting membrane potential (Lerche et al., 2005).
Recent reports suggest that Kv7.2 mutations in the channel’s
VSD may be associated with other clinical phenotypes (Dedek
et al., 2001; Wuttke et al., 2007). The R207W and R207Q muta-
tions result in the neutralization of the fourth conserved arginine
of the VSD’s S4 segment (R4W and R4Q). The R207W mutation
has been linked to the development of a BFNC phenotype associ-
ated with PNH (Dedek et al., 2001). The similar R207Qmutation
has been linked to PNH without BFNC (Wuttke et al., 2007).
The R207W biophysical characterization revealed that the
mutation causes a depolarizing shift in the voltage-dependence
and a drastic slowing of activation resulting in a loss of chan-
nel function. This would probably explain the BFNC and PHN
phenotype (Dedek et al., 2001). When Kv7.2 and Kv7.3 were
co-expressed to potentially mimic a probable physiological con-
dition, this loss of channel function due to the R207W mutation
is still observed (Dedek et al., 2001).
The investigation of the R207Q mutation also revealed a loss
of channel function via similar mechanisms (Wuttke et al., 2007).
However, this loss of channel function disappeared in condi-
tions potentially mimicking the situation of a patient carrying the
R207Q mutation (co-expression of Kv7.2/R207Q, Kv7.2/WT, and
Kv7.3 subunit) (Wuttke et al., 2007).
The localization of R207Q and R207W mutations led the
researchers to suspect and then confirm the presence of gating
pore current. Due to low Kv7.2 channel expression, the pres-
ence of gating pore current was investigated in homologous Kv7.4
channels. It was thus found that reproducing the R207Q or
R207Wmutations caused the creation of a gating pore. Since this
channel is similar to the Kv7.2 channel, it is reasonable to assume
that the gating pore current observed in Kv7.4 would be similar
in Kv7.2 channels.
Therefore, the common PNH phenotype observed could be
due to the gating pore current induced by the R207W/Q muta-
tions. Indeed, in conditions close to the physiology, the R207Q
mutation did not seem to change channel’s function while the
R207W mutation induced a loss of channel function (Wuttke
et al., 2007). This might thus explain why the BFNC phenotype is
observed with the R207Wmutation whereas the R207Qmutation
only causes PNH.
The pathophysiological process could be similar to the one
observed with the R675Wmutation (R3W) of the Nav1.4 isoform
causing NormoPP previously discussed. The Na+ leak caused
by gating pore currents could facilitate the generation of action
potentials by lowering the threshold, thus leading to neuronal
hyperexcitability.
OTHER GATING PORE LINKED PATHOLOGIES
To date, HypoPP, NormoPP, arrhythmic familial DCM and PNH
are the only pathologies that have been clearly associated with
gating pore currents. However, recent reports, based solely on the
location of the mutation, have indicated that other pathologies
may be linked to gating pore currents. A total of 28 mutations on
the S4 segments of Nav, Cav, and Kv have been described. These
mutations cause six other pathologies (LQTS, familial hemiplegic
migraine, epilepsy, benign familial neonatal infantile seizures,
familial episodic pain, and malignant hyperthermia susceptibil-
ity) (Figure 7) (Scalmani et al., 2006; Striessnig et al., 2010;
Jurkat-Rott et al., 2012; Zhang et al., 2013). However, the associa-
tion between gating pores and these pathologies are hypothetical
and more studies are required to confirm the presence of gating
pores. As such, these assumptions should be treated with cau-
tion. Similar assumptions have been made about the R1448C and
R1448H Nav1.4 mutations (R1–S4/DIV) (Sokolov et al., 2007).
These mutations have been linked to the occurrence of paramy-
otonia congenital (Chahine et al., 1994b). Gating pore currents
should appear, based on the location of the mutation (first argi-
nine on S4 of DIV). However, the R1448C mutation does not
induce a gating pore current (Francis et al., 2011), which was
recently confirmed by Gosselin-Badaroudine et al. (2012a). It is
thus far from certain that a given mutation will induce a gating
pore current based solely on the site of the mutation.
PHARMACOLOGY
BLOCKERS AS RESEARCH TOOLS
A few gating pore blockers have been tentatively identified.
However, due to the wide diversity of the immediate environment
of gating pores, no universal blocker has yet been identified.
Divalent cations such as barium (Ba2+), zinc (Zn2+), and
Ca2+ are effective in the millimolar (mM) range (Table 4). These
cations block gating pores created by the arginine-to-glycine sub-
stitution of the second arginine of the S4 segment in DII of
Nav1.4 (R666G) (Sokolov et al., 2007). Nickel (Ni2+), cadmium
(Cd2+), and barium (Ba2+), on the other hand, do not block gat-
ing pores created by the R663H mutation in Nav1.4 (Table 4)
(Struyk and Cannon, 2007). Possible explanations include the
location of the mutation and the nature of the gating pore cur-
rent since gating pores induced by the R666G mutation conduct
monovalent cations while the R663H mutant channel specifically
conducts H+.
Conflicting results have been published. Sokolov et al. stud-
ied the R666G mutation in Nav1.4 and reported that gating pores
can be blocked by divalent cations (Sokolov et al., 2007) while
Struyk et al. reported that divalent cations do not block gating
pores (Table 4) (Struyk et al., 2008). This result was the sub-
ject of some debate until it was discovered that divalent cations
do indeed block gating pores created by the R666G mutation
in a voltage-dependent manner (Sokolov et al., 2010). Trivalent
and quadrivalent ions (gadolinium Gd3+, ytterbium Yb3+, lan-
thanum La3+, lutetium Lu3+, yttrium Y3+, titanium Ti3+, and
hafniumHf4+) have also been reported to block gating pores, but
in a voltage-independent manner (Sokolov et al., 2010).
The arginine residue can be considered as a natural gating pore
blocker since gating pore currents appear following the substitu-
tion of the arginine on the S4 segment of VSDs (Figures 3, 4).
Some researchers are thus investigating molecules derived from
the side chain of arginine as blockers. The arginine side chain
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Table 4 | Ions and molecules tested as gating pore blockers.
Channel Mutation Location Ions Guanidinium derivatives References
Block No effect Block No effect
dShaker R362C/E283D R1/E1 Mg2+ Ethyl-guanidium Tombola et al., 2005
rNav1.4 R666G DII/R2 Ca2+, Zn2+, Ba2+ Sokolov et al., 2007
rNav1.4 R663H DII/R1 Li+, Ni2+, Cd2+,
Ba2+
Struyk and Cannon,
2007
rNav1.4 R666G DII/R2 Ca2+, Zn2+, Ba2+ Struyk et al., 2008
N.at-Kv3.2 None∗ None∗ Ba2+ Klassen et al., 2008
rNav1.4 R666G DII/R2 Ca2+, Zn2+, Y3+,
Ba2+, La3+, Yb3+,
Lu3+, Hf4+, Tl3+
1-(2,4-xylyl)
guanidine-carbonate
Ethyl-
guanidium
Sokolov et al., 2010
hHv1 R211S R3 Zn2+ Berger and Isacoff,
2011
rNav1.4 R1125Q DIII/R2 Ni2+, Zn2+ Ca2+, Ba2+ Francis et al., 2011
hNav1.5 R219H DI/R1 Ni2+, Zn2+,
Cd2+,La3+
Ethyl-
guanidium
Gosselin-
Badaroudine et al.,
2012b
*For N.at-Kv3.2, no substitution was required to induce a gating pore.
contains a guanidine. Interestingly, guanidinium ions permeate
through gating pores while guanidinium derivatives such as ethyl-
guanidinium and 1-(2,4-xylyl) guanidine carbonate have been
reported to block gating pores (Table 4) (Tombola et al., 2005;
Sokolov et al., 2010).
Gating pore blockers can be useful research tools, but the vari-
ability in published data is puzzling. Several investigators have
reported that divalent and trivalent cations can block gating
pores (Sokolov et al., 2007, 2010; Wu et al., 2011), while others
have reported the opposite (Table 4) (Struyk and Cannon, 2007;
Francis et al., 2011; Gosselin-Badaroudine et al., 2012b). This
discrepancy may be due to differences in the environments sur-
rounding the gating pores. However, investigators studying the
same mutation have reported opposite results (Sokolov et al.,
2007; Struyk et al., 2008) In this case, the discrepancy may be
due to differences in the experimental methods (Sokolov et al.,
2010). The voltage-dependence of the block may also explain the
discrepancy. New studies are needed to clarify this issue.
Gating modifier toxins can also be useful in fundamental
research. These toxins can stabilize the VSDs of various ion chan-
nels in their resting or activated state. Six toxin binding sites (sites
1–6) have been identified in Nav, with site 4 located in the VSD
of DII (Cestele and Catterall, 2000). Toxins that affect site 4 can
be used to modulate ion permeation through gating pores. For
example, toxins in the same category as β-scorpion and β-spider
toxins, including Css4 (Centruroides suffusus suffusus toxin 4), Tsγ
(Tityus serrulatus gamma toxin), Lqhβ1 (Leiurus quinquestriatus
hebraeus Beta 1 toxin), AahIT (Androctonus australisHector Insect
Toxin), and Magi 5 (Macrothele gigas toxin 5) stabilize VSDs in
their activated state (Martin et al., 1987; Chahine et al., 1998;
Possani et al., 1999; Corzo et al., 2003; Stevens et al., 2011). In
contrast, toxins such as μ-Oconotoxins (MrVIA and MrVIB) as
well as HWTX-IV (Huwentoxin-IV) have the same binding site
as β-scorpion toxins (site 4), but stabilize VSDs in their resting
state (Leipold et al., 2007; Xiao et al., 2008).
TARGETING VSDs AS A THERAPEUTIC APPROACH
None of the reported gating pore blockers has been shown to be
clinically relevant. When the pathology is known to be caused
by gating pore currents, patients only benefit from symptomatic
treatment targeting the downstream consequences of the muta-
tion (paralysis or arrhythmias). Before a gating pore blocker can
be used on a given patient, its effectiveness has to be verified
in vitro on the patient’s specificmutation. This is of critical impor-
tance since there are no known universal gating pore blockers.
Most drugs target the central alpha pore. However, the fact that
gating pore currents play a role in pathogenic processes will help
in the development of new therapies that target VSDs. For exam-
ple, molecules such as NH29 (a diclofenac derivative), a gating
modifier that promotes the opening of the Kv7.2 channel (Peretz
et al., 2007, 2010), could be a starting point for the development
of new drugs.
Given the diversity of the mutations, targeting VSDs could be
an effective strategy for sidestepping the variability of the muta-
tions (nature of the mutations, nature of the pathological current,
voltage dependence). Modulating VSDs would stabilize a given
mutated S4 segment in the activated or resting state in order to
prevent water crevices from communicating and, as such, prevent
gating pore currents. For example, β-scorpion toxins bind to site
4 on the Nav channel and stabilize the S4 segment of DII in its
activated state (Catterall et al., 2007). Unfortunately, the precise
impact of each S4 segment and their possible cooperation in the
gating of the alpha pores of the Nav and Cav channels need to be
clarified. Maintaining the gating properties and alpha pore func-
tions of channels is a major challenge for developing therapies
to specifically treat gating pore current-induced pathologies. So
far, only 1-(2,4-xylyl) guanidine carbonate (Table 4) appears to
be an efficient, specific blocker that could be used on most gating
pores, especially since it does not modify the gating properties
of the alpha pore (Sokolov et al., 2010). It would be very interest-
ing to test 1-(2,4-xylyl) guanidine carbonate in the two transgenic
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animal models of HypoPP (Wu et al., 2011, 2012) in which the
phenotype is caused by a Nav1.4 mutation in one model and a
Cav1.1 mutation in the other. It would also allow the blocker to
be tested on different gating pores.
Developing approaches to modulate VSDs to treat chan-
nelopathies should also be considered. Even if such studies reveal
that changing gating properties should be avoided in the case of
gating pore currents, they could lead to new therapeutic avenues
for treating cell excitability disorders and channelopathies such as
LQTS and BrS. In addition, therapies that prevent the activation
of specific Nav (Nav1.7 or Nav1.8) channels might also be valu-
able in treating pain while avoiding the addictive side effect of
currently available drugs.
PERSPECTIVES AND CONCLUSIONS
The recent discovery of gating pore currents provides a fresh
perspective in the field of electrophysiology. Gating pores are
a promising new tool for the investigation of VSD structures
and functions. Only a few crystal structures of VGICs have
been reported. Moreover, the structures of only six TM chan-
nels have been elucidated (Jiang et al., 2003; Long et al., 2005,
2007; McCusker et al., 2012; Payandeh et al., 2012; Zhang et al.,
2012). Gating pore currents are thus a powerful tool for inves-
tigating similarities and differences between VSDs. Simulations
based on existing crystal structures have been used to understand
and predict the complex tridimensional structures of Nav and
Cav channels (Tao et al., 2010; Delemotte et al., 2011; Khalili-
Araghi et al., 2012). Gating pore currents could be used to pro-
vide restrictive criteria to build computational models that more
closely mimic physiological conditions. Gating pores have also
been studied to better understand the environment (hydrophilic
and hydrophobic) and functioning (sequence of activation of the
various domains, movement of the S4 segment) of VGICs.
To date, four phenotypes have been clearly associated with the
appearance of gating pore currents (HypoPP, NormoPP, arrhyth-
mic DCM and PNH). These pathologies are caused by mutations
on Nav, Cav or Kv channels. However, suitable environments for
the creation of gating pores can be found in most proteins con-
taining a VSD. It is thus surprising that gating pore currents have
only been detected in one pathology associated with Kv chan-
nel mutations. This may be due to the relative novelty of gating
pores or to the highly deleterious impact of gating pore currents
induced by the tetrameric nature of Kv channels. Similar hypoth-
esis might explain why only fewmutations located on the S2 or S3
segments of VSDs have been related to the development patholog-
ical phenotypes. Such mutations in the GCTC would also disrupt
interactions between the GCTC and the S4 segment leading to
the appearance of a gating pore current. The resulting gating pore
would be constitutively activated as the interactions between the
GCTC and the S4 segment would be disrupted for all the possible
states of the VSD. Nevertheless, this phenomenon has never been
observed and remains to be elucidated.
Future discoveries might reveal pathologies caused by the dis-
appearance of gating pore currents. Indeedmutations that abolish
or modify the currents carried by Hv1 channels might lead to the
discovery of an association with various pathologies given their
broad distribution.
Lastly, gating pore currents are a novelty in the field of VGICs
and are a promising tool for structure-function investigations.
Studies on gating pore currents provide new insights into familial
diseases and may help identify the causes of various pathologies
and, as such, the development of new therapeutic approaches.
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